Trials / Conditions / Invasive Pneumococcal Disease

Invasive Pneumococcal Disease

7 registered clinical trials studyying Invasive Pneumococcal Disease.

Status	Trial	Sponsor	Phase
Completed	An Epidemiological Survey to Establish the Spectrum of Circulating Serotypes of S. Pneumoniae, in Patients Old NCT04464291	The Interregional Association for Clinical Microbiology and Antimicrobial Chemotherapy (IACMAC)	N/A
Completed	Study Estimating the Impact of Prevnar 13™ (13vPnC) on Invasive Pneumococcal Disease NCT01128439	Pfizer	—
Completed	Impact of PCV on Disease and Colonization Among Native American Communities NCT01083459	Johns Hopkins Bloomberg School of Public Health	—
Completed	Immune Response In Children Revaccinated With Pneumococcal Conjugate Vaccine NCT00853749	Wyeth is now a wholly owned subsidiary of Pfizer	Phase 3
Unknown	7-valent Pneumococcal Conjugated Vaccination NCT00885625	National Taiwan University Hospital	Phase 4
Completed	Study Evaluating Prevenar in the Prevention of Invasive Pneumococcal Disease (IPD) in the Paediatric Populatio NCT00227188	Pfizer	—
Completed	Immunogenicity of 7-Valent Pneumococcal Conjugate Vaccine in Lung Fluid of Adults With and Without HIV Infecti NCT00371878	Royal Liverpool University Hospital	Phase 4